ClinicalTrials.gg
CompletedNCT05271383CMF-ORTHOUpdated Oct 7, 2026

Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery

An observational study in Orthognathic Surgery, Maxillofacial Abnormalities and Maxilla Fracture, sponsored by Global D. Completed at 1 site in France. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Global D · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
198
Sex
All
01

Study summary

This study is set up within the framework of the European Union regulation 2017/745 on medical devices. Its objective is to confirm the performance and safety of the Global D implants (ORTRAUTEK® and MINITEK®) used for orthognathic surgery.

Read the detailed description

Study design : Non-interventional, prospective, multicentric, national, open-label, non-comparative study.

Investigators : 7 sites in France.

A statistical evaluation will be performed on those data in order to determine the performance and the security of those devices.

02

Conditions studied

  • Orthognathic Surgery
  • Maxillofacial Abnormalities
  • Maxilla Fracture

Keywords

  • Orthognathic surgery
  • Performance
  • Security
  • Plates
  • Screw
  • Medical device
  • Cranio-maxillofacial
03

In context

Maxillofacial Abnormalities

21 studies on the registry are indexed under Maxillofacial Abnormalities; 2 are open to participants now.

Browse Maxillofacial Abnormalities studies →

Lead sponsor

Global D is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population is composed of male and female, major or minor, who will be treated by orthognatic surgery (maxillary, mandibular, maxillomandibular or/with genioplasty). The bone maturity of the participants (assessed by investigators) need to be sufficient for the treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female patient, major or minor, having reached bone maturity according to the judgement of the investigator,
  • Patient having first orthognathic surgery (maxillary, mandibular, maxillomandibular or/with genioplasty)
  • Patient who received orthodontic treatment prior to orthognathic surgery.
  • Patient with abilities to read, understand and answer to the study quality of life questionnaire.
  • Patient (and his legal representative if minor) who signed the study consent form.
  • Patient affiliated to a social security system.

Exclusion criteria

Exclusion Criteria:

  • Patient allergic to one of the components of the implants
  • Patient with physical or mental inabilities that will compromise the follow-up during the study
  • Patient with acute or chronic infection (local or systemic)
  • Person on legal protection
  • Pregnant or breastfeeding women
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
198 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Study group

    Male and female, major or minor, who will be treated by orthognathic surgery (maxillary, mandibular, maxillomandibular or/with genioplasty). The bone maturity of the participants (assessed by investigators) need to be sufficient for the treatment.

    Device: Orthognathic surgery using Global D's implants.

Interventions

  • DeviceOrthognathic surgery using Global D's implants.

    Major or minor participants who will be treated by an orthognathic surgery with ORTRAUTEK® or MINITEK® implant(s).

06

What researchers measure

Primary outcomes

  1. Performance of the Global D's implants used for orthognathic surgery, assessed by the Orthognathic Quality of Life Questionnaire (OQLQ) before and after the surgery.

    The evolution of patient's quality of life will be assessed by comparing the score of the Orthognathic Quality of Life Questionnaire (OQLQ) before and after the surgery. The OQLQ can vary from 0 (better quality of life) to 88 (worst quality of life).

    Time frame: 1 year

Secondary outcomes

  1. Security of the Global D implants used for orthognathic surgery - Outcome Measure 1a

    Bone consolidation after the surgery, assessed by a correct dental occlusion on the postoperative image. This information is assessed 6 weeks after the surgery: correct occlusion (Yes/No).

    Time frame: 6 weeks after the surgery

  2. Security of the Global D implants used for orthognathic surgery - Outcome Measure 1b

    Bone consolidation after the surgery, assessed by the alimentation of the patient. This information is assessed 6 weeks after the surgery: solid alimentation of the patient (Yes/No).

    Time frame: 6 weeks after the surgery

  3. Security of the Global D implants used for orthognathic surgery - Outcome Measure 2

    Adverse events identification, assessment and follow-up.

    Time frame: 18 months

  4. Surgeon satisfaction on the implant's utilisation

    Assessment by a satisfaction questionnaire, specially developed for the study, completed by the surgeon after the surgery. The surgeon evaluates each item using a likert scale (Highly Satisfied/ Satisfied/ Not very satisfied / Unsatisfied).

    Time frame: Immediately following surgery

07

Study locations

1 site
  • CHU de Nantes
    Nantes, 44000, France
08

Updates

2 registry updates since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
2 updates, last Oct 7, 2026
Show all 2 updates
  1. Oct 7, 2026
    Minor edits only
    + 1 other change: verification date
  2. Oct 2, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05271383
Lead sponsor
Global D
Responsible party
Sponsor
First posted
Mar 9, 2022
Start date
Feb 4, 2022
Primary completion
Aug 2, 2024
Completion
Aug 2, 2024
Last update
Oct 7, 2026

Study contacts

Pierre CORRE, MD
principal investigator · Cranio-maxillofacial surgeon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion